UCB SA of Belgium has acquired, for an undisclosed sum, research assets from venture-capital backed Lectus Therapeutics Ltd of the UK as well as rights to the company’s technology platform for ion channel discovery. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
